Product Information
TRIENTINE HCL 250 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $2.8388 per EA under NDC 00591491001. Its NADAC has been published 46 times since Jun 18, 2025.
The High Outlier badge above means this manufacturer's average price in the Trientine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591491001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
TRIENTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207567On Market Since
2/8/2018
Pharmacological Classes
Price Statistics
The NADAC for TRIENTINE HCL 250 MG CAPSULE has been published 46 times since Jun 18, 2025, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8388 per EA |
|---|---|
| All-time high | $4.4843 (Jul 16, 2025) |
| All-time low | $2.8388 (Apr 22, 2026) |
| 52-week high | $4.4843 |
| 52-week low | $2.8388 |
| Median price | $4.3033 |
| Average price | $4.1695 |
| Largest weekly change | -21.6% (Mar 18, 2026) |
| Weeks tracked | 46 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRIENTINE HCL 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TRIENTINE HCL 250 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $2.8388 per EA (NDC 00591491001), effective Apr 29, 2026.
How has the price of TRIENTINE HCL 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TRIENTINE HCL 250 MG CAPSULE has declined 36.7%. It has been tracked across 46 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for TRIENTINE HCL 250 MG CAPSULE?
Since Jun 18, 2025, the NADAC for TRIENTINE HCL 250 MG CAPSULE has ranged from a low of $2.8388 (Apr 22, 2026) to a high of $4.4843 (Jul 16, 2025), with a median of $4.3033 per EA.
Are there cheaper alternatives to TRIENTINE HCL 250 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TRIENTINE HCL 250 MG CAPSULE, is $2.3025 per EA — about 19% below TRIENTINE HCL 250 MG CAPSULE.
Who manufactures TRIENTINE HCL 250 MG CAPSULE?
TRIENTINE HCL 250 MG CAPSULE (NDC 00591491001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.